Hi-Tech Pharmacal Co., Inc. (HITK)
-NasdaqGS 33.81 
0.07(0.21%) May 22, 4:00PM EDT|After Hours
:
34.27 0.46 (1.36%) May 22, 5:26PM EDT
| Prev Close: | 33.74 |
|---|
| Open: | 33.84 |
|---|
| Bid: | N/A |
|---|
| Ask: | 35.70 x 200 |
|---|
| 1y Target Est: | 38.67 |
|---|
| Beta: | 0.24 |
|---|
| Next Earnings Date: | 8-Jul-13 |
|---|
| Day's Range: | 33.53 - 34.57 |
|---|
| 52wk Range: | 27.35 - 38.17 |
|---|
| Volume: | 58,623 |
|---|
| Avg Vol (3m): | 61,594 |
|---|
| Market Cap: | 458.84M |
|---|
| P/E (ttm): | 14.99 |
|---|
| EPS (ttm): | 2.26 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- HITK Makes Bullish Cross Above Critical Moving Averageat TheStreet(Wed, May 22)
- HITK January 2014 Options Begin Tradingat TheStreet(Mon, May 20)
- Hi-Tech Pharmacal's Management Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)at Seeking Alpha(Tue, May 14)
- Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care ConferenceBusiness Wire(Thu, May 9)
- ECR Pharmaceuticals Announces Re-launch of Zolpimist® and DexPak®, Divestiture of Hylase® and Orbivan® Brands, and Dr. Cameron Durrant Named President and CEOBusiness Wire(Tue, Apr 30)
- Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare ConferenceBusiness Wire(Mon, Apr 29)
- HI-Tech Pharmacal (HITK) Shares Cross Above 200 DMAat TheStreet(Tue, Apr 23)
- Healthcare Sector: High Quality Stocks At A Great Valueat TheStreet(Mon, Mar 18)
- HI TECH PHARMACAL CO INC FinancialsEDGAR Online Financials(Wed, Mar 13)
- HI TECH PHARMACAL CO INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PrincEDGAR Online(Wed, Mar 13)
- Hi Tech Pharmacal Misses Where it Countsat Motley Fool(Mon, Mar 11)
- New Star Analyst Rankings for Hi-Tech Pharmacal Co., Inc.StarMine(Sat, Mar 9)
- Investors Ride 4 Earnings Rollercoaster Ridesat Wall St. Cheat Sheet(Sat, Mar 9)
- HI TECH PHARMACAL CO INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Fri, Mar 8)
- HI TECH PHARMACAL CO INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, Mar 8)
Key Statistics
| Forward P/E (1 yr): | 12.86 |
|---|
| P/S (ttm): | 1.95 |
|---|
| Ex-Dividend Date: | 11-Dec-12 |
|---|
Analysts
| Annual EPS Est
(Apr-13)
: | 2.18 |
|---|
| Quarterly EPS Est
(Apr-13)
: | 0.65 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | -1.71 |
|---|
Business Summary
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription and over-the-counter (OTC) products in the United States.
View More